Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$440K Sell
2,575
-64
-2% -$10.7K ﹤0.01% 1767
2019
Q3
$435K Sell
2,639
-7,491
-74% -$1.05M ﹤0.01% 1727
2019
Q2
$1.21M Buy
10,130
+8,139
+409% +$834K 0.01% 1010
2019
Q1
$189K Buy
1,991
+1,118
+128% +$95.8K ﹤0.01% 2328
2018
Q4
$70K Sell
873
-356
-29% -$30.1K ﹤0.01% 2950
2018
Q3
$131K Buy
1,229
+581
+90% +$54.4K ﹤0.01% 2541
2018
Q2
$56K Buy
648
+64
+11% +$5.74K ﹤0.01% 3006
2018
Q1
$51K Buy
584
+55
+10% +$4.27K ﹤0.01% 3048
2017
Q4
$36K Buy
529
+248
+88% +$16.3K ﹤0.01% 3312
2017
Q3
$16K Buy
281
+200
+247% +$10.9K ﹤0.01% 3698
2017
Q2
$3K Sell
81
-25
-24% -$1.08K ﹤0.01% 4424
2017
Q1
$4K Buy
106
+27
+34% +$1.16K ﹤0.01% 4215
2016
Q4
$3K Hold
79
﹤0.01% 4126
2016
Q3
$3K Hold
79
﹤0.01% 4081
2016
Q2
$2K Buy
+79
New +$2.46K ﹤0.01% 4116

Other funds holding PODD

Advisor Group's PODD Position: Q4 2019 in Review

Advisor Group reduced its Insulet (PODD) stake by 2.4% in Q4 2019, selling an estimated $10.7K and leaving 2,575 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

Advisor Group first reported a position in PODD in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.21M in Q2 2019. 376 funds tracked by Wall St. Rank hold PODD as of Q4 2019.

  • Advisor Group held 2,575 shares of Insulet worth $440K as of Q4 2019.
  • Advisor Group sold 64 Insulet shares in Q4 2019, an estimated $10.7K.
  • Insulet made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1767 holding.
  • Advisor Group first reported a position in Insulet in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Insulet position peaked at $1.21M in Q2 2019.
  • 376 funds tracked by Wall St. Rank held Insulet as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.